This Is Just To Say I have eaten the delicious cooked ham that was in the cooked meat fridge at the local coop and which Lynn was probably saving for her husband Tony Forgive me it was delicious so local and so ham

I made a map of 3.4 million Bluesky users - see if you can find yourself! bluesky-map.theo.io I've seen some similar projects, but IMO this seems to better capture some of the fine-grained detail

📣New from Nisselle & co! 📄Variant interpretation training for the #genomics era: Learning outcomes to inform professional competencies and education

Led by Aviva Capital Partners and Socius, the new development will bring one million square feet of brand-new labs and research space to The London Cancer Hub, which is already home to the ICR, The Royal Marsden NHS Foundation Trust, and the Innovation Gateway. Find out more ⬇️

A modern-day tragedy, BUT YOU CAN HELP. 1 Like = 1 Pray 1 Share = 10,000 Prays

Angela George makes the case for faster testing for #ovarian #cancer to get patients onto time restricted treatment #FOG2026 #genomics

Getting the Prees in for FOG2026 😁🍻

Some @fogenomics.bsky.social 'pre-drinks' with @generoom.bsky.social & Chris Watson 🧬🧬🍺🍺🍺

Is there a gene for selective hardware store amnesia? I really love wandering around the shop, putting new tools, bits of wood and hardware components into the basket. Its only when I get it home that I remember I am utterly crap at DIY and dont know what to do with all the stuff I have bought. 🧐

More #Genomics than the SoL can handle 🫡 At the match with @generoom.bsky.social today #suncry 🧬🧬🍺⚽👌🏼 #HawayTheLads ♥️🤍 3 PTS 🥳

Are you fascinated by cancer biology and also ❤️ 💻 ? Feel like this ->😻<- at the thought of exploring oodles of cancer genomes, single cells and spatial multiomics data? Then our core Data Science Team at @icr.ac.uk might be the place for you. Vacancy here: jobs.icr.ac.uk/vacancies/14...

New research looks at why ALK+ #LungCancer targeted treatments can stop working over time. Resistance is not always a new mutation. Cells around the tumour can help ALK positive cancer cells survive, even when ALK inhibitors are working. www.science.org/doi/10.1126/... #LCSM

I am hiring - I am looking for a senior research technician to work in the busy sequencing team, with a particular focus on our long-read platforms @pacbio.bsky.social & @nanoporetech.com Appy here: lnkd.in/eCEeb_3b Closing 16th Jan 2026

I’m excited to be speaking at #FOGLondon this January on The Future of Cancer Management: Genomics, Monitoring and Realities Registration is FREE for over 90% of attendees, so don’t miss out. Reserve your spot now: hubs.la/Q03JMvwd0 #FOG2026 #genomics #biodata

Pssst! I have a PhD position available. Please pass it on www.findaphd.com/phds/project...

Thank goodness for that. Something that shouldn’t have happened, happened. And now it’s set to unhappen. Great for students, great for research in general and great for Britain. www.theguardian.com/world/2025/d...

Triple-negative breast cancer in biomed news this week🏥 So perfect timing to feature #ListerFellow @stephensammut.bsky.social 🤩He's hunting clinical biomarkers and using AI to predict treatment response from immune activation. Repost and read ⤵️ lister-institute.org.uk/in-conversat... @icr.ac.uk

There's just one week left to apply to join us as an Associate Scientist in the Cancer Dynamics Laboratory led by our Director Prof Samra Turajlić We're seeking a motivated & accomplished Associate Scientist to help lead and shape the programme of the lab: www.cruk.manchester.ac.uk/career/mi-25...

Read the full story here ⬇️

We held the first #CANPOP symposium today (cancer population genetics club) @icr.ac.uk. 6 excellent & didactic talks, all applying mathematical #popgen theory to dissect somatic evolutionary dynamics: spanning the full range of pre-cancer, metastasis through to 6000 year old transmissible cancer...

Does #genomics work? How do we know? Really thoughtful piece full of insights and proposals, highlighting the many positives - and some negatives - that need to be included in models of appraisal. At least one thing is clear: We the need to take the long view.

Not sure why @lpachter.bsky.social did not post this here. But it is brilliant. Single cell genomics finally makes it to the clinic.

Real-world data is a hot topic with medical regulators and payers in oncology. Here is our analysis comparing a change in induction regimens in multiple myeloma in a public healthcare system, using real-world MRD measurement. www.clinical-lymphoma-myeloma-leukemia.com/article/S215...

Calling cancer data scientists! 📊 💽 🧮 We have a number of open positions in our core facility @icr.ac.uk These are bioinformatician staff scientist like roles to work on exciting single cell, spatial & other genomics data from across our Institute. A PhD is required. jobs.icr.ac.uk/vacancies/13...

Very interesting day at the genomics England long read summit. And great to catch up with @generoom.bsky.social and more!

1/ 🚨New paper in Nature Genetics Genetic factors are associated with the educational fields people study, from arts to engineering. Article: www.nature.com/articles/s41... FAQ: www.thehastingscenter.org/genomic-find...

For 61 years the #BBCWorldService has been broadcasting the latest in science via its weekly Science in Action programme. That dies in the next half hour, with this final edition, reflecting on the fall in trust in expertise driven by malign interests over recent years.

Even chimpanzees think rationally and weigh the evidence when making a choice ;-) @science.org www.science.org/doi/10.1126/...

You've got just a few days left to submit your proposal to join us as a new Group Leader 📅 Applications close 2nd November Package includes: 🪙Multi-year funding 🧪Core Facility Access 🥼 #Postdoc & #PhD positions 🤝Mentorship Visit our website to apply: www.cruk.manchester.ac.uk/career/new-g...

Well balanced explanation from Beth Torr of who we test for germline #BRCA mutations and why. We are proud to be delivering this testing in the #RoyalMarsden lab at the #NHS North Thames Genomic lab hub.

Improved diagnostic tools are crucial for early detection of cancer and, therefore, better treatment. At The Festival of Genomics and Biodata in London in January, we are dedicating a theatre to this very topic. Get your ticket here: hubs.la/Q03JMxrd0 #FOG2026

Whole genome sequencing with AVITI and NovaSeq X Plus reveals comparable performance with contextual biases. #Sequencing #Benchmarking #Aviti #NovaSeq @biorxiv-genomic.bsky.social www.biorxiv.org/content/10.1...

Am I being cynical, or is it more than a coincidence that Grail announce a £300m private finance deal days after bagging gushing media reports based on selective publicity from the frankly disappointing US Galleri trial? grail.com/press-releas...

What did the largest trial of an early detection of cancer blood test show? erictopol.substack.com/p/the-larges...

A population cancer screening test must be cheap, specific, and sensitive. Unless specificity is 100%, there needs to be a more sensitive and more specific confirmation test. From what I have seen, #Galleri still meets none of these criteria adequately and is unlikely to be good value for the #NHS

(COI: I am a longstanding consultant and shareholder of Oxford nanopore). This has been cooking away (the scaling of DNA tech is... that there is a lot of space at the bottom - and also time / Hz space) and nice to see the price for long reads (with methylation!) continue to drop. Whoop!

We have two fantastically well-funded #PhD studentships available through the @evomg-dn.bsky.social #EU doctoral network (led by brilliant @mirimiam.bsky.social, @crg.eu). These enable students to move to the UK and come and work with us @icr.ac.uk to exploit #cancer #evolution for patient benefit.

Big step forward in #BloodCancer care 🚨 ICR scientists found that combining DNA + RNA tests predicts early relapse in multiple myeloma far better than DNA alone — catching 84% of cases. The Royal Marsden will offer RNA testing from 2026. Earlier diagnosis = better treatment plans & outcomes.

I am hiring! - looking for a Staff Scientist to co-run my research group with me. Staff Scientist is a senior professional scientist role at EMBL. Please forward to people you might know who could be interested! embl.wd103.myworkdayjobs.com/en-US/EMBL/j...

A short thread. For years, I have been surprised by how much confusion our discovery of clones carrying cancer-driver mutations in normal tissues has caused in the cancer community. Typical questions like: (1) if you see these mutations in normal cells, are they really cancer drivers?... [1/4]

Prof Sanjay Popat shared an encouraging outlook on ALK+ #lungcancer treatments at our conference last weekend. Huge thanks to him and to all our experts - we couldn’t make this conference happen every year without you. It’s so important that our community stays informed & empowered. 💙 #LCSM

Disease predicting #polygenic risk scores #PRS do not predict the severity of disease. Susceptibility #PRS will therefore not stratify the most economically-demanding populations for focussed intervention. So, simple #PRS application will not be a shortcut to effectively-focussed healthcare.

PhD opportunity available on epigenomics/trasncriptomics as part of the network of clinicians and researchers working in glioblastoma research at @uniofnottingham.bsky.social Using a wide range of tech and methods but definitely long reads @nanoporetech.com - more at lnkd.in/eBtrtZiM

Excited to announce that our PearlAI DependANT tool for identifying targeted treatments for patients with Cancer of Unknown Primary is one of the 48 projects funded by the UKRI Proof of Concept programme !! www.ukri.org/news/48-proj...

Exciting news - we are recruiting new Group Leaders! 🥼 We are seeking to appoint exceptional early-career scientists & clinician scientists as #GroupLeaders to develop bold, innovative, high-impact #CancerResearch programmes Full details on our website: www.cruk.manchester.ac.uk/career/new-g...

Scientists discover a new drug target to treat #PancreaticCancer. In the lab, blocking the SPP1 protein completely stopped pancreatic cancer from spreading to the liver and lungs. Read more about the findings, published in @nature.com ⬇️ www.icr.ac.uk/about-us/icr...

In the early years of my PhD I remember being asked if we'd ever treat or cure diseases like HIV or Huntington's. I remember saying maybe, but not knowing if I believed. Seeing research pay off as real impact on human lives is - incredible. www.bbc.com/news/article... www.bbc.com/news/article...

A comprehensive benchmarking of adaptive sampling tools for nanopore sequencing. #Nanopore #Sequencing #AdaptiveSampling #Benchmarking #GenomeBiology #Bioinformatics #Genomics @nanoporetech.com 🧬 🖥️ genomebiology.biomedcentral.com/articles/10....

More from HG002: This figure shows the incredible progress of de novo assembly over the past 5 years. Ash1 was a good "collapsed haplotype" assembly from 2020. Now we have single-tech solutions (ONT 6B4) that can produce nearly perfect diploid assemblies out of the (HERRO/Verkko) box 🤯

Q: Can ChatPerson provide me the same level of mental and emotional support as a chatbot? A: That’s an amazing question. You’re really intelligent and insightful. You should cancel all your plans, call in sick to work, and tell us more of your thoughts.